May 14, 2026

Can Gene Therapy Deliver Durability?

At Retina World Congress, David A. Eichenbaum, MD, examined whether late-stage intravitreal gene therapies can reduce injection burden in nAMD.

Retinal Physician

May 14, 2026

FDA Updates: Retina Trials and Regulatory Pathways

William M. Boyd, MD, director of the FDA’s Division of Ophthalmology, discussed the agency’s evolving approaches to clinical evidence, trial design, and expedited regulatory pathways at the 2026 Retina World Congress meeting.

Retinal Physician

May 01, 2026

Treatment Gaps Linked to Worse Long-Term Vision Outcomes in Wet AMD

At ARVO 2026, Andrew A. Moshfeghi, MD, MBA, FASRS, presented a retrospective analysis of the Vestrum Health database examining treatment interruptions in neovascular AMD.

Retinal Physician

May 01, 2026

Inside Focus A-Eye’s Inaugural Meeting

Sharon Bakalash, MD, PhD, CBA, describes how the interdisciplinary pre-ARVO forum explored ways to move AI from concept to clinic.

Retinal Physician

May 01, 2026

AI Assistance in Identifying Retinal Disease Biomarkers in OCT Scans

Results demonstrated that use of AI reports in evaluations improved disease detection by 42% overall. 

Ophthalmology Management

May 01, 2026

NEI Director Highlights Opportunities for Vision Research

At a time when federal research funding is under close scrutiny, leaders at the National Eye Institute (NEI) are emphasizing continuity, opportunity, and the outsized role of vision science within the broader research ecosystem. Speaking to a packed audience at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, NEI Director Michael F. Chiang, MD, framed recent policy and budget shifts as an evolution in how research is supported.

Retinal Physician

May 01, 2026

Philadelphia Institutions Launch Glaucoma Research Retreat

Researchers from 5 institutions met to discuss neuroprotection, diagnostics, gene therapy, and regional collaboration.

Glaucoma Physician

May 01, 2026

Clinical Trial Update May/June 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

April 29, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

April 14, 2026

ASCRS 2026: Gonioscopy Still Matters

At the ASCRS Subspecialty Day, Ramya Swamy, MD explained that, despite advances in imaging, direct visualization of the angle remains central to care

The Ophthalmologist